Cargando…
Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report
INTRODUCTION: Although myasthenia gravis is frequently associated with other disorders, it has not been reported together with primary sclerosing cholangitis, complicating the administration of liver-toxic immunosuppressive therapy. CASE PRESENTATION: A 73-year-old Caucasian woman with a history of...
Autores principales: | Finsterer, Josef, Höflich, Sonja |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988809/ https://www.ncbi.nlm.nih.gov/pubmed/21059205 http://dx.doi.org/10.1186/1752-1947-4-356 |
Ejemplares similares
-
Coexistence of primary sclerosing cholangitis in a patient with myasthenia gravis
por: Lorenzoni, P. J., et al.
Publicado: (2011) -
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022) -
Nonmelanoma skin cancer risk awareness in azathioprine‐treated myasthenia gravis patients
por: McGurgan, Iain J., et al.
Publicado: (2015) -
Azathioprine: Myasthenia gravis crisis secondary to COVID-19 pneumonitis: case report
Publicado: (2021) -
Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)